Geoffrey S. Dow, President and CEO at 60 DEGREES PHARMACEUTICALS, INC. (SXTP), bought 7,350 shares at $1.38 ($10K) on 2026-06-12, disclosed to the SEC on 2026-06-15.
60 Degrees Pharmaceuticals CEO Geoffrey S. Dow purchased 7,350 shares for $10,131.24 on June 12, 2026, marking the largest purchase of his career and signaling confidence in the stock's potential recovery. The trade comes as the stock has dropped 83.26% over the past year and is currently trading near its 52-week low.
SXTP is down 83.26% over the last year and 33.93% over the last 90 days, currently trading at $1.48, which is 86.26% below its 52-week high of $10.77 but only 19.35% above its 52-week low of $1.24.
1) The company was upgraded to a Zacks Rank #2 (Buy) on April 3, 2026, reflecting growing optimism about earnings prospects. 2) On February 2, 2026, 60 Degrees Pharmaceuticals announced a partnership with GoodRx to expand access to ARAKODA, enhancing the medication's affordability and accessibility. 3) The CEO's purchase is the largest of his career, potentially signaling a bullish stance on the stock's future.
1) The stock is down 83.26% over the past year, indicating significant volatility and potential continued downside risk. 2) The company has a short interest of 7.8% of the float, which could lead to additional selling pressure if the stock fails to recover.
Something here stands out, but not much.
| Filing → |
| SXTP | BUY | 2024-12-09 | $90K | — | Filing → |
| SXTP | BUY | 2024-11-21 | $6K | — | Filing → |
| SXTP | BUY | 2024-02-02 | $10K | — | Filing → |